Financials Beijing Strong Biotechnologies,Inc.

Equities

300406

CNE100001Y26

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E. 06:00:00 2024-05-27 pm EDT 5-day change 1st Jan Change
16.91 CNY -1.57% Intraday chart for Beijing Strong Biotechnologies,Inc. -2.03% -11.47%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 8,159 14,737 11,674 9,611 11,206 9,913 - -
Enterprise Value (EV) 1 8,159 14,737 11,674 9,611 11,206 9,913 9,913 9,913
P/E ratio 24.6 x 119 x 28.7 x 24.4 x 21.7 x 16.2 x 13.1 x 10.7 x
Yield - - - 0.61% - 1.42% 1.71% 2.07%
Capitalization / Revenue 9.7 x 17.4 x 7.3 x 6.36 x 6.43 x 4.93 x 4.16 x 3.52 x
EV / Revenue 9.7 x 17.4 x 7.3 x 6.36 x 6.43 x 4.93 x 4.16 x 3.52 x
EV / EBITDA - 79,754,215 x - 13,523,933 x - - - -
EV / FCF - - - - - - - -
FCF Yield - - - - - - - -
Price to Book - 4.61 x 4.06 x 3.12 x 3.02 x 2.36 x 2.05 x 1.76 x
Nbr of stocks (in thousands) 501,788 588,997 588,984 587,124 586,727 586,193 - -
Reference price 2 16.26 25.02 19.82 16.37 19.10 16.91 16.91 16.91
Announcement Date 2/28/20 3/25/21 4/26/22 4/19/23 3/29/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 840.9 848.1 1,599 1,511 1,742 2,012 2,380 2,814
EBITDA - 184.8 - 710.7 - - - -
EBIT 1 - 153 535.9 455.5 593.9 705.5 860.5 1,061
Operating Margin - 18.05% 33.5% 30.15% 34.1% 35.06% 36.15% 37.7%
Earnings before Tax (EBT) 1 - 136.9 537 449.4 593.6 706 860 1,061
Net income 1 - 112.3 405.7 389.1 523.7 615.4 757 933.8
Net margin - 13.24% 25.36% 25.76% 30.07% 30.58% 31.8% 33.18%
EPS 2 0.6600 0.2100 0.6900 0.6700 0.8800 1.045 1.290 1.585
Free Cash Flow - - - - - - - -
FCF margin - - - - - - - -
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share 2 - - - 0.1000 - 0.2400 0.2900 0.3500
Announcement Date 2/28/20 3/25/21 4/26/22 4/19/23 3/29/24 - - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow - - - - - - - -
ROE (net income / shareholders' equity) - 4.46% 12.1% 12.7% 14.9% 14.5% 15.6% 16.6%
ROA (Net income/ Total Assets) - - - 8.71% - 10.3% 10.9% 11.5%
Assets 1 - - - 4,466 - 5,975 6,945 8,120
Book Value Per Share 2 - 5.430 4.880 5.250 6.330 7.180 8.250 9.590
Cash Flow per Share 2 - 0.2100 0.5800 0.6700 0.9900 0.7100 1.120 1.340
Capex 1 - 16.9 65 96.5 147 126 136 151
Capex / Sales - 1.99% 4.06% 6.39% 8.44% 6.26% 5.71% 5.37%
Announcement Date 2/28/20 3/25/21 4/26/22 4/19/23 3/29/24 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
16.91
Average target price
-
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 300406 Stock
  4. Financials Beijing Strong Biotechnologies,Inc.